Author:
Eickhoff A,Martin W,Hartmann D,Eickhoff J C,Möhler M,Galle P R,Riemann J F,Jakobs R
Publisher
Springer Science and Business Media LLC
Reference9 articles.
1. Angelucci A, Alesse E, Trotta I (1997) Schedule-dependent and additive effects of doxorubicin and gemcitabine on tumor cell apoptosis. Tumori 83: 129–130
2. Burris III HA (2005) Recent updates on the role of chemotherapy in pancreatic cancer. Semin Oncol 32: S1–S3
3. Burris III HA, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD, Von Hoff DD (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15: 2403–2413
4. Hess V, Salzberg M, Borner M, Morant R, Roth AD, Ludwig C, Hermann R (2003) Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: a phase I/II trial. J Clin Oncol 21: 66–68
5. Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47: 207–214
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献